| Financial Year |
March 31 2023 |
| Monetary Funds |
825,114,852.08 |
| Held-for-trading Financial Assets |
26,240,608.55 |
| Notes Receivable |
338,661,390.35 |
| Accounts Receivable |
1,463,081,717.58 |
| Advances to Suppliers |
46,989,192.13 |
| Other Receivables |
71,901,589.91 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,143,169,439.98 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
235,658,928.87 |
| Total Current Assets |
4,150,817,719.45 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
126,170,520.86 |
| Investment Properties |
39,400,926.54 |
| Fixed Assetes |
1,700,420,605.24 |
| Under-construction Projects |
166,552,252.37 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
151,566,780.61 |
| R&D expenses |
-- |
| Goodwill |
130,636,249.46 |
| Long-Term Deferred and Prepaid Expenses |
3,803,812.35 |
| Deferred Income Tax Assets |
28,424,190.22 |
| Other Non-Current Assets |
250,383,098.17 |
| Sub-Total of Non-Current Assets |
2,677,219,724.45 |
| Total Assets |
6,828,037,443.90 |
| Short-Term Loans |
203,848,062.30 |
| Trading Financial liabilities |
-- |
| Notes Payable |
343,299,450.71 |
| Accounts Payable |
866,078,566.15 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
30,559,688.32 |
| Taxes Payable |
23,134,425.09 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
14,885,291.93 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
20,131,573.06 |
| Other Current Liabilities |
5,298,531.20 |
| Sub-Total of Current Liabilities |
1,511,805,369.65 |
| Long-term Loans |
112,927,014.24 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
3,717,641.25 |
| Deferred Income Tax Liabilities |
13,162,508.33 |
| Other Non-Current Liabilities |
48,000,000.00 |
| Sub-Total of Non-Current Liabilities |
225,069,470.54 |
| Total Liabilities |
1,736,874,840.19 |
| Paid-In Capital(Or Share Stock) |
842,101,491.00 |
| Capital Surplus |
1,634,183,572.84 |
| Surplus Reserve |
368,622,888.03 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
2,251,790,726.65 |
| Minority Stockholder's Interest |
25,125,967.99 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
5,066,036,635.72 |
| Owner's Equity（Stockholder's Equity） |
5,091,162,603.71 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
6,828,037,443.90 |
